Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling
Sponsor: Aswan University
Summary
Investigators are going to assess direct effect of SGLT2 inhibitors on left atrial remodeling in participants with nonvalvular paroxysmal atrial fibrillation regardless of diabetes status.
Official title: Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrium Remodeling in Non-valvular Paroxysmal Atrial Fibrillation Patients
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-08-20
Completion Date
2025-10-15
Last Updated
2026-07-13
Healthy Volunteers
No
Conditions
Interventions
Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
10 mg of Dapagliflozin orally once daily
Rhythm control and anticoagulation
In acute stage: Cardioversion with D.C shock if haemodynamically unstable, after failure of pharmacological cardioversion or participant preference. or pharmacological cardioversion with either IV cordarone in structurally abnormal heart (150mg over 10 minutes followed by1 mg/min infusion for 6 hours followed by 0.5 mg/min not exceeding 2.4 grams over 24 hours till restoration of sinus Rhythm. Then maintenance dose of 200 mg tab orally every 8 hours for 3 weeks then 200 mg tab orally once per day. or Propafenone (Rytmonorm) 600 mg single oral dose in structurally normal heart then maintenance dose of 150mg tab orally every 8 hours. \+ Rivaroxaban 20mg orally once daily if CHA2DS2 VASc score 1 or more for males and 2 or more for females.
Locations (1)
Aswan university
Aswān, Aswan Governorate, Egypt